New laser device aims to lower eye pressure better in glaucoma surgery trial

NCT ID NCT06246136

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study compares two devices used during cataract surgery to treat open-angle glaucoma. About 194 adults with mild to moderate glaucoma and cataracts will receive either the ELIOS device or a competitor device. The main goal is to see which one lowers eye pressure more effectively after 12 months.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for OPEN-ANGLE GLAUCOMA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • ELIOS Clincal Site

    RECRUITING

    Madrid, Spain

  • ELIOS Clinical Site

    RECRUITING

    Leuven, Belgium

  • ELIOS Clinical Site

    RECRUITING

    Bordeaux, France

  • ELIOS Clinical Site

    RECRUITING

    Bochum, Germany

  • ELIOS Clinical Site

    RECRUITING

    Maastricht, Netherlands

  • ELIOS Clinical Site

    RECRUITING

    East Grinstead, United Kingdom

  • ELIOS Clinical Site

    RECRUITING

    Edinburgh, United Kingdom

  • ELIOS Clinical Site

    RECRUITING

    Guildford, United Kingdom

  • ELIOS Clinical Site

    RECRUITING

    Manchester, United Kingdom

  • ELIOS Clinical site

    RECRUITING

    Madrid, Spain

  • ELIOS clinical site

    RECRUITING

    Paris, France

  • ELIOS clinical site

    RECRUITING

    Heidelberg, Germany

  • ELIOS clinical site

    RECRUITING

    Barcelona, Spain

  • ELIOS clinical site

    RECRUITING

    London, United Kingdom

  • Elios Clinical Site

    RECRUITING

    Avranches, France

  • Elios clinical site

    RECRUITING

    Bonn, Germany

More trials for these conditions

Other studies related to the condition(s) this trial covers.